Related Experiment Video
Updated: Feb 23, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Frailty and subclinical coronary atherosclerosis: The Multicenter AIDS Cohort Study (MACS)
Sai Krishna C Korada1, Di Zhao2, Martin Tibuakuu3
1Northeast Ohio Medical University, Rootstown, OH, USA.
Insights
Frailty is linked to coronary atherosclerosis in HIV-uninfected men but not in HIV-infected men. Further research is needed to understand these differences and potential interventions for cardiovascular health.
Area of Science:
- Gerontology
- Cardiology
- Infectious Diseases (HIV/AIDS)
Background:
- Frailty and cardiovascular disease share common risk factors.
- Understanding the independent association between frailty and subclinical coronary atherosclerosis is crucial.
- Investigating potential differences in this association based on HIV-serostatus is important.
Purpose of the Study:
- To evaluate if frailty is independently associated with subclinical coronary atherosclerosis.
- To determine if the relationship between frailty and coronary atherosclerosis differs between HIV-uninfected and HIV-infected individuals.
Main Methods:
- Study included 976 male participants from the Multicenter AIDS Cohort Study (62% HIV-infected).
- Frailty assessed using 5 criteria (weakness, slowness, weight loss, exhaustion, low physical activity).
- Subclinical coronary atherosclerosis evaluated using coronary artery calcium (CAC) and coronary CT angiography (CCTA) for plaque scoring (TPS, MPS, NCPS).
Main Results:
- Frailty was more prevalent in HIV-infected men (14.3%) compared to HIV-uninfected men (7.5%).
- Frailty was associated with coronary artery calcium (CAC>0), total plaque score (TPS>0), and mixed plaque score (MPS>0) in HIV-uninfected men after adjustments.
- No significant association between frailty and subclinical coronary atherosclerosis was observed in HIV-infected men.
Conclusions:
- Frailty is independently associated with subclinical coronary atherosclerosis in HIV-uninfected men.
- This association was not found in HIV-infected men, suggesting a potential difference based on HIV status.
- Further research is warranted to explore the underlying mechanisms and the impact of frailty interventions on cardiovascular outcomes.
Background And Aims:
Frailty and cardiovascular disease share many risk factors. We evaluated whether frailty is independently associated with subclinical coronary atherosclerosis and whether any relationships differ by HIV-serostatus.
Methods:
We studied 976 [62% HIV-infected] male participants of the Multicenter AIDS Cohort Study who underwent assessment of frailty and non-contrast cardiac CT scanning; of these, 747 men also underwent coronary CT angiography (CCTA). Frailty was defined as having ≥3 of 5 of the following: weakness, slowness, weight loss, exhaustion, and low physical activity. Coronary artery calcium (CAC) was assessed by non-contrast CT, and total plaque score (TPS), mixed plaque score (MPS), and non-calcified plaque score (NCPS) by CCTA. Multivariable-adjusted regression was used to assess the cross-sectional associations between frailty and subclinical coronary atherosclerosis.
Results:
Mean (SD) age of participants was 54 (7) years; 31% were black. Frailty existed in 7.5% and 14.3% of HIV-uninfected and HIV-infected men, respectively. After adjustment for demographics, frailty was significantly associated with prevalence of any CAC (CAC>0), any plaque (TPS>0), and mixed plaque (MPS>0) in HIV-uninfected but not in HIV-infected men (p-interactionHIV<0.05 for all). Among HIV-uninfected men, after adjustment for cardiovascular risk factors, frailty was significantly associated only with CAC>0 [Prevalence Ratio 1.27 (95%CI 1.02, 1.59)] and TPS>0 [1.19 (1.06, 1.35)]. No association was found for NCPS.
Conclusions:
Frailty was independently associated with subclinical coronary atherosclerosis among HIV-uninfected men, but not among HIV-infected men. Further work is needed to ascertain mechanisms underlying these differences and whether interventions that improve frailty (i.e. strength training) can improve cardiovascular outcomes.
More Related Videos
06:43Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
Published on: December 7, 2013
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Atherosclerosis I: Introduction